Trulieve Earnings + Call Notes
U.S. canna leader talks through Q323.
$275M Revs; est. 269M
(-2.48% q/q; -6.8% y/y)
$78M AEBITDA; est. $72M
(-22% y/y)
$143M GP; est. $136.5M
52% GM vs. est. 51.5%
(vs. 56% last year)
($0.12) EPS; est. ($0.17)
Q3 CFFO $93M; FCF $87M
est. FY23 CFFO $100M+; FCF $70M+
Call Notes
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.